rs9518320

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_052867.4(NALCN):​c.1839+8822T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.242 in 152,132 control chromosomes in the GnomAD database, including 5,223 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.24 ( 5223 hom., cov: 32)

Consequence

NALCN
NM_052867.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.904

Publications

3 publications found
Variant links:
Genes affected
NALCN (HGNC:19082): (sodium leak channel, non-selective) This gene encodes a voltage-independent, nonselective cation channel which belongs to a family of voltage-gated sodium and calcium channels that regulates the resting membrane potential and excitability of neurons. This family is expressed throughout the nervous system and conducts a persistent sodium leak current that contributes to tonic neuronal excitability. The encoded protein forms a channelosome complex that includes G-protein-coupled receptors, UNC-79, UNC-80, NCA localization factor-1, and src family tyrosine kinases. Naturally occurring mutations in this gene are associated with infantile neuroaxonal dystrophy, infantile hypotonia with psychomotor retardation and characteristic facies (IHPRF) syndrome, and congenital contractures of the limbs and face with hypotonia and developmental delay (CLIFAHDD) syndrome. A knockout of the orthologous gene in mice results in paralysis with a severely disrupted respiratory rhythm, and lethality within 24 hours after birth. [provided by RefSeq, Apr 2017]
NALCN Gene-Disease associations (from GenCC):
  • congenital contractures of the limbs and face, hypotonia, and developmental delay
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • hypotonia, infantile, with psychomotor retardation and characteristic facies 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • digitotalar dysmorphism
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Freeman-Sheldon syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Sheldon-hall syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hypotonia, infantile, with psychomotor retardation and characteristic facies
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • temporal lobe epilepsy
    Inheritance: AD Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.0).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.318 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NALCNNM_052867.4 linkc.1839+8822T>C intron_variant Intron 15 of 43 ENST00000251127.11 NP_443099.1 Q8IZF0-1A0A024RE05

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NALCNENST00000251127.11 linkc.1839+8822T>C intron_variant Intron 15 of 43 1 NM_052867.4 ENSP00000251127.6 Q8IZF0-1

Frequencies

GnomAD3 genomes
AF:
0.242
AC:
36771
AN:
152014
Hom.:
5225
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.126
Gnomad AMI
AF:
0.409
Gnomad AMR
AF:
0.192
Gnomad ASJ
AF:
0.262
Gnomad EAS
AF:
0.0334
Gnomad SAS
AF:
0.282
Gnomad FIN
AF:
0.313
Gnomad MID
AF:
0.218
Gnomad NFE
AF:
0.322
Gnomad OTH
AF:
0.252
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.242
AC:
36769
AN:
152132
Hom.:
5223
Cov.:
32
AF XY:
0.240
AC XY:
17855
AN XY:
74374
show subpopulations
African (AFR)
AF:
0.126
AC:
5250
AN:
41540
American (AMR)
AF:
0.192
AC:
2936
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.262
AC:
909
AN:
3472
East Asian (EAS)
AF:
0.0336
AC:
174
AN:
5172
South Asian (SAS)
AF:
0.281
AC:
1353
AN:
4814
European-Finnish (FIN)
AF:
0.313
AC:
3311
AN:
10566
Middle Eastern (MID)
AF:
0.201
AC:
59
AN:
294
European-Non Finnish (NFE)
AF:
0.322
AC:
21879
AN:
67964
Other (OTH)
AF:
0.250
AC:
526
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
1366
2732
4097
5463
6829
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
394
788
1182
1576
1970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.275
Hom.:
783
Bravo
AF:
0.227
Asia WGS
AF:
0.165
AC:
572
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
3.4
DANN
Benign
0.70
PhyloP100
-0.90
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9518320; hg19: chr13-101819829; API